Here we designed and synthesized analogs of two antimicrobial peptides, namely C10:0-A2, a lipopeptide, and TA4, a cationic α-helical amphipathic peptide, and used non-proteinogenic amino acids to improve their therapeutic properties. The physicochemical properties of these analogs were analyzed, including their retention time, hydrophobicity, and critical micelle concentration, as well as their antimicrobial activity against gram-positive and gram-negative bacteria and yeast. Our results showed that substitution with D- and N-methyl amino acids could be a useful strategy to modulate the therapeutic properties of antimicrobial peptides and lipopeptides, including enhancing stability against enzymatic degradation. The study provides insights into the design and optimization of antimicrobial peptides to achieve improved stability and therapeutic efficacy. TA4(dK), C10:0-A2(6-NMeLys), and C10:0-A2(9-NMeLys) were identified as the most promising molecules for further studies.
The ability of the liver, small intestine, and kidney to synthesize and subsequently eliminate dinitrophenyl-S-glutathione (DNP-SG), a substrate for multidrug resistance-associated protein 2 (Mrp2), was assessed in rats treated with glucagon-like peptide 2 (GLP-2, 12 μg/100 g b.wt. s.c. every 12 h for 5 consecutive days). An in vivo perfused jejunum model with simultaneous bile and urine collection was used. A single intravenous dose of 30 μmol/kg b.wt. 1-chloro-2,4-dinitrobenzene (CDNB) was administered, and its conjugate, DNP-SG, and dinitrophenyl cysteinyl glycine (DNP-CG), resulting from the action of γ-glutamyltransferase on DNP-SG, were determined in bile, intestinal perfusate, and urine by high-performance liquid chromatography. Tissue content of DNP-SG was also assessed in liver, intestine, and kidneys. Biliary excretion of DNP-SG+DNP-CG was decreased in GLP-2 rats with respect to controls. In contrast, their intestinal excretion was substantially increased, whereas urinary elimination was not affected. Western blot and real-time polymerase chain reaction studies revealed preserved levels of Mrp2 protein and mRNA in liver and renal cortex and a significant increase in intestine in response to GLP-2 treatment. Tissue content of DNP-SG detected 5 min after CDNB administration was decreased in liver, increased in intestine, and unchanged in kidney in GLP-2 versus control group, consistent with GLP-2-induced down-regulation of expression of glutathione transferase (GST) Mu in liver and up-regulation of GST-Alpha in intestine at both protein and mRNA levels. In conclusion, GLP-2 induced selective changes in hepatic and intestinal disposition of a common GST and Mrp2 substrate administered systemically that could be of pharmacological or toxicological relevance under therapeutic treatment conditions.
Metacyclogenesis is a critical process in the Trypanosoma cruzi life cycle. This transition naturally occurs in an insect vector’s gut. Although Triatomine Artificial Urine (TAU) medium is the widely adopted approach to metacyclogenesis in vitro, its efficiency decreases with prolonged epimastigote culture, limiting the availability of metacyclic trypomastigotes for study. We aimed to establish a practical and efficient method for generating high concentrations and purities of metacyclic trypomastigotes in vitro. Epimastigotes of the Dm28c strain were exposed to pH shifts in nutrient-rich (MT-LIT) and nutrient-poor (M16) media, under static or agitated conditions. Both media promoted higher metacyclogenesis rates than TAU, with epimastigotes’ adherence to the substrate being a crucial factor. Metacyclogenesis efficiency varies depending on the strains and culture conditions. Notably, both LIT and M16 at pH 6 produced metacyclic trypomastigotes with infective capacity on Vero cells. Under these conditions, a variety of intermediate forms were observed compared to those induced by TAU metacyclogenesis. Our findings further emphasize the strain-dependent nature of optimal in vitro metacyclogenesis conditions and offer new opportunities for studying the intermediate forms involved in this essential process.
Metacyclogenesis is a critical process during Trypanosoma cruzi life cycle. This transition naturally occurs in the insect vector’s gut, influenced by temperature, nutrient availability and pH fluctuations, among others. Triatomine Artificial Urine (TAU) medium is the widely adopted approach to metacyclogenesis in vitro. However, this becomes less effective when epimastigotes are cultured for long periods, limiting the study of the metacyclic trypomastigote stage. We aimed to establish a practical and efficient method for generating high concentrations and purity of metacyclic epimastigotes in vitro. Epimastigotes of the Dm28c strain were exposed to pH shifts in nutrient-rich (MT-LIT) and nutrient-poor (M16) media, under static or agitated conditions. Results showed that both media promoted higher metacyclogenesis rates than TAU, with epimastigotes adherence to the substrate being crucial factor. Metacyclogenesis efficiency varies depending on the strains and culture conditions. LIT and M16 at pH 6 produced metacyclic trypomastigotes with infective capacity on Vero cells. Under these conditions, a variety of intermediate forms were observed compared to those induced by TAU metacyclogenesis. Our findings further emphasize the strain-dependent nature of optimal in vitro metacyclogenesis conditions and offer new opportunities for studying the intermediate forms involved in this essential process.